FindTrial
Sign In

Which Treatment Works Best for Chronic Heel Pain? Comparing PRP with Nerve Block, PRP Alone, and Steroid Injections

Comparative Evaluation of Platelet-Rich Plasma Injections with Baxter s Nerve Block vs Platelet-Rich Plasma Injections Alone vs Corticosteroid Injections in the Management of Chronic Plantar Fasciitis: A Pilot Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087247
Enrollment
45
Registered
2025-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Platelet-Rich Plasma Injections with Baxter s Nerve Block vs Platelet-Rich Plasma Injections Alone vs Corticosteroid Injections: This study will involve three treatment groups, each rec

Sponsors

AIIMS Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age greater than or equal to 18 years, either sex. 2. Clinical diagnosis of plantar fasciitis for at least 3 months, plus ultrasound confirmed thickening of the plantar fascia ( greater than 4 mm at the insertion). 3. Pain score (NRS) greater than or equal 5/10 at baseline. 4. Failure of conservative treatments (NSAIDs, exercises, orthotics, etc.) for at least 6 weeks. 5. Willingness to provide written informed consent and comply with follow-up visits.

Exclusion criteria

Exclusion criteria: 1. Previous foot or ankle surgery within the last 6 months. 2. Systemic diseases or conditions that may impair healing (e.g., uncontrolled diabetes, significant peripheral vascular disease, rheumatoid arthritis, autoimmune disorders). 3. Coagulopathies or ongoing use of anticoagulants that contraindicate injection therapy. 4. Pregnant or breastfeeding women. 5. Neurological conditions affecting foot sensation (e.g., peripheral neuropathy) or pain perception. 6. Any contraindication to local anesthetics or PRP (e.g., local infection, severe anemia, platelet dysfunction).

Design outcomes

Primary

MeasureTime frame
Reduction in heel pain, measured using Numeric Rating Scale . Plantar fascia thickness measurement using UltrasoundTimepoint: baseline, 6 weeks,and 12 weeks post-treatment.—

Secondary

MeasureTime frame
Functional Improvement: Assessed through the Foot and Ankle Disability Index (FADI)Timepoint: baseline, 6 weeks,and 12 weeks post-treatment.;Patient Satisfaction: Measured through a patient satisfaction questionnaireTimepoint: baseline, 6 weeks,and 12 weeks post-treatment.—

Countries

India

Contacts

Public ContactDr Ajit Kumar

AIIMS Rishikesh

ajit.anaes@aiimsrishikesh.edu.in9910789377

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026